BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26865355)

  • 1. Intratumor heterogeneity in clear cell renal cell carcinoma: a review for the practicing pathologist.
    López JI
    APMIS; 2016 Mar; 124(3):153-9. PubMed ID: 26865355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Snail heterogeneity in clear cell renal cell carcinoma.
    Zaldumbide L; Erramuzpe A; Guarch R; Pulido R; Cortés JM; López JI
    BMC Cancer; 2016 Mar; 16():194. PubMed ID: 26951092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological Bases and Clinical Impact of Intratumor Heterogeneity in Clear Cell Renal Cell Carcinoma.
    López JI; Angulo JC
    Curr Urol Rep; 2018 Jan; 19(1):3. PubMed ID: 29374850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High levels of intratumor heterogeneity characterize the expression of epithelial-mesenchymal transition markers in high-grade clear cell renal cell carcinoma.
    Guarch R; Lawrie CH; Larrinaga G; Angulo JC; Pulido R; López JI
    Ann Diagn Pathol; 2018 Jun; 34():27-30. PubMed ID: 29661723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity in renal cell carcinoma.
    Beksac AT; Paulucci DJ; Blum KA; Yadav SS; Sfakianos JP; Badani KK
    Urol Oncol; 2017 Aug; 35(8):507-515. PubMed ID: 28551412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A divide-and-conquer strategy in tumor sampling enhances detection of intratumor heterogeneity in routine pathology: A modeling approach in clear cell renal cell carcinoma.
    Lopez JI; Cortes JM
    F1000Res; 2016; 5():385. PubMed ID: 27127618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD34 immunostaining enhances a distinct pattern of intratumor angiogenesis with prognostic implications in clear cell renal cell carcinoma.
    López JI; Erramuzpe A; Guarch R; Cortés JM; Pulido R; Llarena R; Angulo JC
    APMIS; 2017 Feb; 125(2):128-133. PubMed ID: 28120493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal tumors with clear cells. A review.
    López JI
    Pathol Res Pract; 2013 Mar; 209(3):137-46. PubMed ID: 23433880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumor C-reactive protein as a biomarker of prognosis in localized renal cell carcinoma.
    Johnson TV; Ali S; Abbasi A; Kucuk O; Harris WB; Ogan K; Pattaras J; Nieh PT; Marshall FF; Osunkoya AO; Master VA
    J Urol; 2011 Oct; 186(4):1213-7. PubMed ID: 21849188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
    Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clear Cell Renal Cell Carcinomas with Aggressive Behavior Display Low Intratumor Heterogeneity at the Histological Level.
    Manini C; López-Fernández E; Lawrie CH; Laruelle A; Angulo JC; López JI
    Curr Urol Rep; 2022 Jun; 23(6):93-97. PubMed ID: 35416538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Convergent insights into intratumor heterogeneity.
    Manini C; Laruelle A; Rocha A; López JI
    Trends Cancer; 2024 Jan; 10(1):12-14. PubMed ID: 37684129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multisite tumor sampling: a new tumor selection method to enhance intratumor heterogeneity detection.
    López JI; Cortés JM
    Hum Pathol; 2017 Jun; 64():1-6. PubMed ID: 28237785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovering intratumor heterogeneity: the next frontier for pathologists.
    López JI; De Petris G
    Pathologica; 2017 Jun; 109(2):110-113. PubMed ID: 28748969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GALNT4 predicts clinical outcome in patients with clear cell renal cell carcinoma.
    Liu Y; Liu W; Xu L; Liu H; Zhang W; Zhu Y; Xu J; Gu J
    J Urol; 2014 Nov; 192(5):1534-41. PubMed ID: 24769034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The pathologist's role in the neoadjuvant strategy of renal-cell carcinoma].
    Leroy X; Edeline J; Rioux-Leclercq N
    Ann Pathol; 2011 Dec; 31(6):466-71. PubMed ID: 22172119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical challenges and implications of intratumor heterogeneity].
    Palacios J; Matías-Guiu X; Rodríguez-Peralto JL; de Álava E; López JI
    Rev Esp Patol; 2019; 52(4):234-241. PubMed ID: 31530406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clear cell renal cell carcinoma with a syncytial-type multinucleated giant tumor cell component: implications for differential diagnosis.
    Williamson SR; Kum JB; Goheen MP; Cheng L; Grignon DJ; Idrees MT
    Hum Pathol; 2014 Apr; 45(4):735-44. PubMed ID: 24499686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastasis of renal-cell carcinoma: a pathologist's theoretical view.
    Vetter JM
    Prog Clin Biol Res; 1990; 348():13-22. PubMed ID: 2201033
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.